Ratings by TD Cowen (Yaron Werber)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/4/2026 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
| 2/19/2026 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2026 | Upstream Bio | UPB | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2026 | Upstream Bio | UPB | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2026 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2026 | Legend Biotech Corp. | LEGN | Downgrade | Hold (Buy) |
23.42 (18.97) |
-19% | Details | |
| 1/20/2026 | Rapt Therapeutics | RAPT | Downgrade | Hold (Buy) |
35.10 (58.02) |
65.3% | Details | |
| 1/7/2026 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2026 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2025 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2025 | Rapt Therapeutics | RAPT | New Coverage | Buy (N/A) |
33.18 (35.10) |
5.79% | Details | |
| 12/17/2025 | Vor Biopharma, Inc. | VOR | New Coverage | Buy (N/A) |
15.82 (15.12) |
-4.42% | Details | |
| 12/3/2025 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 11/24/2025 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2025 | BeOne Medicines | ONC | Maintain | (N/A) |
|
Details | ||
| 11/5/2025 | Ultragenyx Pharma | RARE | Maintain | (N/A) |
|
Details | ||
| 11/5/2025 | Exelixis | EXEL | Maintain | (N/A) |
|
Details | ||
| 11/3/2025 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 10/31/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2025 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 10/22/2025 | Alector Inc. | ALEC | Downgrade | Hold (Buy) |
3.31 (2.00) |
-39.58% | Details | |
| 10/16/2025 | Dianthus Therapeutics | DNTH | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 10/9/2025 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 10/2/2025 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 9/30/2025 | Genmab A/S | GMAB | Maintain | Hold (N/A) |
|
Details | ||
| 9/30/2025 | IO Biotech | IOBT | Downgrade | Hold (Buy) |
1.58 (0.30) |
-81.01% | Details | |
| 9/10/2025 | PMV Pharmaceuticals Inc. | PMVP | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2025 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
| 9/2/2025 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2025 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2025 | Genmab A/S | GMAB | Maintain | Hold (N/A) |
|
Details | ||
| 8/7/2025 | BeOne Medicines | ONC | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2025 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2025 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 8/1/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 7/10/2025 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2025 | Jasper Therapeutics | JSPR | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2025 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 6/11/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 6/10/2025 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2025 | Zymeworks | ZYME | New Coverage | Buy (N/A) |
11.82 (24.08) |
103.72% | Details | |
| 5/14/2025 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2025 | Legend Biotech Corp. | LEGN | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2025 | Spring Works Therapeutics | SWTX | Downgrade | Hold (Buy) |
44.72 (46.99) |
5.08% | Details | |
| 4/17/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 4/10/2025 | Legend Biotech Corp. | LEGN | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2025 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 3/10/2025 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2025 | BeiGene Ltd. | ONC | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2025 | Genmab A/S | GMAB | Maintain | Hold (N/A) |
|
Details | ||
| 2/13/2025 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2025 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2025 | Spring Works Therapeutics | SWTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/21/2025 | Forte Biosciences Inc. | FBRX | New Coverage | Buy (N/A) |
15.60 (28.76) |
84.36% | Details | |
| 12/20/2024 | Dianthus Therapeutics | DNTH | New Coverage | Buy (N/A) |
23.27 (65.20) |
180.19% | Details | |
| 12/17/2024 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
| 11/27/2024 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 11/26/2024 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 11/19/2024 | Septerna Inc | SEPN | New Coverage | Buy (N/A) |
23.55 (28.78) |
22.21% | Details | |
| 11/15/2024 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2024 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2024 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2024 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 11/5/2024 | Upstream Bio | UPB | New Coverage | Buy (N/A) |
25.15 (7.66) |
-69.54% | Details | |
| 10/28/2024 | Celldex Therapeutics | CLDX | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2024 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2024 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 10/21/2024 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2024 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2024 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2024 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2024 | Jasper Therapeutics | JSPR | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2024 | Legend Biotech Corp. | LEGN | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2024 | Genmab A/S | GMAB | Maintain | Hold (N/A) |
|
Details | ||
| 10/8/2024 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 10/2/2024 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 10/1/2024 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 9/27/2024 | Celldex Therapeutics | CLDX | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2024 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2024 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2024 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 9/11/2024 | Stoke Therapeutics | STOK | Maintain | Buy (N/A) |
|
Details | ||
| 9/11/2024 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2024 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 9/6/2024 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 9/6/2024 | Alector Inc. | ALEC | Maintain | Buy (N/A) |
|
Details | ||
| 9/4/2024 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 8/19/2024 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2024 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 8/15/2024 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2024 | Genmab A/S | GMAB | Maintain | Hold (N/A) |
|
Details | ||
| 8/7/2024 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2024 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 7/23/2024 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2024 | Legend Biotech Corp. | LEGN | Maintain | Buy (N/A) |
|
Details | ||
| 7/10/2024 | Jasper Therapeutics | JSPR | Maintain | Buy (N/A) |
|
Details | ||
| 6/27/2024 | Spring Works Therapeutics | SWTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2024 | Ascendis Pharma | ASND | Upgrade | Buy (Hold) |
129.39 (240.65) |
85.99% | Details | |
| 6/24/2024 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2024 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2024 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2024 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2024 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2024 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2024 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 4/24/2024 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 4/24/2024 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2024 | Stoke Therapeutics | STOK | Upgrade | Buy (Hold) |
6.50 (35.48) |
445.85% | Details | |
| 3/21/2024 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 3/18/2024 | Jasper Therapeutics | JSPR | New Coverage | Buy (N/A) |
25.08 (1.38) |
-94.5% | Details | |
| 3/15/2024 | Immuneering Corporation | IMRX | Downgrade | Hold (Buy) |
5.88 (5.33) |
-9.35% | Details | |
| 1/31/2024 | 2Seventy Bio Inc. | TSVT | Downgrade | Hold (Buy) |
3.49 (5.00) |
43.27% | Details | |
| 1/25/2024 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2024 | Ascendis Pharma | ASND | Maintain | Hold (N/A) |
|
Details | ||
| 12/21/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2023 | Celldex Therapeutics | CLDX | New Coverage | Buy (N/A) |
37.92 (29.43) |
-22.39% | Details | |
| 12/19/2023 | Ascendis Pharma | ASND | Maintain | Hold (N/A) |
|
Details | ||
| 12/12/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2023 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 10/19/2023 | Generation Bio | GBIO | Downgrade | Hold (Buy) |
3.11 (5.34) |
71.7% | Details | |
| 8/8/2023 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 7/28/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2023 | Stoke Therapeutics | STOK | Downgrade | Hold (Buy) |
9.53 (35.48) |
272.3% | Details | |
| 7/17/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2023 | FibroGen | FGEN | Maintain | Hold (N/A) |
|
Details | ||
| 5/8/2023 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 3/28/2023 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 2/28/2023 | FibroGen | FGEN | Maintain | Hold (N/A) |
|
Details | ||
| 2/27/2023 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
| 1/25/2023 | Ascendis Pharma | ASND | Maintain | Hold (N/A) |
|
Details | ||
| 1/25/2023 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 1/25/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Ascendis Pharma | ASND | Maintain | Hold (N/A) |
|
Details | ||
| 11/3/2022 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2022 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2022 | Legend Biotech Corp. | LEGN | New Coverage | Buy (N/A) |
49.82 (23.42) |
-52.99% | Details | |
| 11/1/2022 | Instil Bio Inc | TIL | Downgrade | Hold (Buy) |
5.25 (8.87) |
68.95% | Details | |
| 8/17/2022 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 8/9/2022 | FibroGen | FGEN | Maintain | Hold (N/A) |
|
Details | ||
| 5/12/2022 | Ascendis Pharma | ASND | Maintain | Hold (N/A) |
|
Details | ||
| 5/10/2022 | FibroGen | FGEN | Maintain | Hold (N/A) |
|
Details | ||
| 5/2/2022 | Genmab A/S | GMAB | New Coverage | Hold (N/A) |
35.07 (27.06) |
-22.84% | Details | |
| 4/6/2022 | bluebird bio | BLUE | Downgrade | Hold (Buy) |
5.23 (4.97) |
-4.97% | Details | |
| 3/31/2022 | Orchard Therapeutics | ORTX | Downgrade | Hold (Buy) |
0.78 (16.70) |
2041.03% | Details | |
| 1/27/2022 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2022 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2022 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2022 | 2Seventy Bio Inc. | TSVT | New Coverage | Buy (N/A) |
22.89 (5.00) |
-78.16% | Details | |
| 1/6/2022 | Ascendis Pharma | ASND | New Coverage | Hold (N/A) |
123.37 (129.39) |
4.88% | Details | |
| 1/6/2022 | 2Seventy Bio | TSTV | New Coverage | Buy (N/A) |
0.00 () |
0% | Details | |
| 11/30/2021 | IO Biotech | IOBT | New Coverage | Buy (N/A) |
8.74 (1.58) |
-81.92% | Details | |
| 11/5/2021 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
| 10/26/2021 | Roivant Sciences | ROIV | New Coverage | Buy (N/A) |
7.04 (28.78) |
308.81% | Details | |
| 10/1/2021 | Acceleron Pharma | XLRN | Downgrade | Hold (Buy) |
175.36 (178.75) |
1.93% | Details | |
| 9/27/2021 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 8/24/2021 | Immuneering Corporation | IMRX | New Coverage | Buy (N/A) |
29.43 (5.88) |
-80.02% | Details | |
| 8/6/2021 | Dicerna Pharmaceuticals | DRNA | Downgrade | Hold (Buy) |
37.92 (38.22) |
0.79% | Details | |
| 7/16/2021 | FibroGen | FGEN | Maintain | Hold (N/A) |
|
Details | ||
| 6/28/2021 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2021 | PMV Pharmaceuticals Inc. | PMVP | New Coverage | Buy (N/A) |
31.03 (1.64) |
-94.71% | Details | |
| 4/13/2021 | Instil Bio Inc | TIL | New Coverage | Buy (N/A) |
21.94 (8.87) |
-59.57% | Details | |
| 3/8/2021 | Nuvation Bio Inc | NUVB | New Coverage | Buy (N/A) |
10.86 (4.59) |
-57.73% | Details | |
| 2/18/2021 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2021 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2021 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2021 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2020 | Prevail Therapeutics | PRVL | Downgrade | Hold (Buy) |
12.50 (23.00) |
84% | Details | |
| 12/15/2020 | Ionis Pharmaceuticals | IONS | Upgrade | Buy (Hold) |
47.83 (74.04) |
54.8% | Details | |
| 12/14/2020 | Olema Pharmaceuticals | OLMA | New Coverage | Buy (N/A) |
43.28 (10.47) |
-75.81% | Details | |
| 11/17/2020 | Foghorn Therapeutics | FHTX | New Coverage | Buy (N/A) |
16.05 (5.78) |
-63.99% | Details | |
| 11/6/2020 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2020 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2020 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 10/22/2020 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Relay Therapeutics | RLAY | New Coverage | Buy (N/A) |
40.69 (9.89) |
-75.69% | Details | |
| 8/7/2020 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2020 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
| 7/30/2020 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2020 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2020 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2020 | Generation Bio | GBIO | New Coverage | Buy (N/A) |
19.64 (5.34) |
-72.81% | Details | |
| 6/25/2020 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2020 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
| 5/26/2020 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2020 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2020 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2020 | FibroGen | FGEN | New Coverage | Hold (N/A) |
36.89 (9.71) |
-73.68% | Details | |
| 2/24/2020 | Epizyme | EPZM | Maintain | Buy (N/A) |
|
Details | ||
| 1/31/2020 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2020 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2020 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2019 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2019 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2019 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2019 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2019 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2019 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
| 10/31/2019 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2019 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2019 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2019 | Spring Works Therapeutics | SWTX | New Coverage | Buy (N/A) |
18.67 (44.72) |
139.53% | Details | |
| 9/16/2019 | argenx SE | ARGX | New Coverage | Buy (N/A) |
124.89 (717.80) |
474.75% | Details | |
| 9/16/2019 | Orchard Therapeutics | ORTX | New Coverage | Buy (N/A) |
15.03 (16.70) |
11.11% | Details | |
| 8/26/2019 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/26/2019 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2019 | Stoke Therapeutics | STOK | New Coverage | Buy (N/A) |
27.85 (35.48) |
27.4% | Details | |
| 7/15/2019 | Prevail Therapeutics | PRVL | New Coverage | Buy (N/A) |
12.13 (23.00) |
89.61% | Details | |
| 6/14/2019 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2019 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2019 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2019 | Alector Inc. | ALEC | New Coverage | Buy (N/A) |
19.59 (3.31) |
-83.1% | Details | |
| 2/26/2019 | Zafgen | ZFGN | New Coverage | Hold (N/A) |
4.84 (0.99) |
-79.55% | Details | |
| 2/26/2019 | Rocket Pharmaceuticals | RCKT | New Coverage | Buy (N/A) |
14.88 (4.41) |
-70.36% | Details | |
| 2/26/2019 | Unum Therapeutics | UMRX | New Coverage | Hold (N/A) |
4.24 (2.35) |
-44.58% | Details | |
| 2/26/2019 | Dicerna Pharmaceuticals | DRNA | New Coverage | Buy (N/A) |
10.51 (38.22) |
263.65% | Details | |
| 2/26/2019 | Exelixis | EXEL | New Coverage | Buy (N/A) |
21.52 (41.55) |
93.08% | Details | |
| 2/26/2019 | Amgen | AMGN | New Coverage | Buy (N/A) |
187.50 (369.53) |
97.08% | Details | |
| 2/26/2019 | BeiGene, Ltd. | BGNE | New Coverage | Buy (N/A) |
137.78 (184.71) |
34.06% | Details | |
| 2/26/2019 | Celgene | CELG | New Coverage | Hold (N/A) |
89.14 (108.24) |
21.43% | Details | |
| 2/26/2019 | bluebird bio | BLUE | New Coverage | Buy (N/A) |
131.32 (4.97) |
-96.22% | Details | |
| 2/26/2019 | Ultragenyx Pharma | RARE | New Coverage | Buy (N/A) |
59.82 (21.25) |
-64.48% | Details | |
| 2/26/2019 | Epizyme | EPZM | New Coverage | Buy (N/A) |
11.85 (1.47) |
-87.59% | Details | |
| 2/26/2019 | Acceleron Pharma | XLRN | New Coverage | Buy (N/A) |
42.74 (178.75) |
318.23% | Details |
